• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Dashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlerts
    Company
    AboutQuantisnow PlusContactJobs
    Legal
    Terms of usePrivacy policyCookie policy

    SEC Form SC 13D filed by Astrotech Corporation (DE)

    6/26/23 4:00:53 PM ET
    $ASTC
    Biotechnology: Laboratory Analytical Instruments
    Industrials
    Get the next $ASTC alert in real time by email
    SC 13D 1 doc1.htm NONE Schedule 13D


    UNITED STATES
    SECURITIES AND EXCHANGE COMMISSION
    Washington, D.C. 20549



    SCHEDULE 13D
    Under the Securities Exchange Act of 1934
    (Amendment No. n/a )*

    Astrotech Corporation

    (Name of Issuer)


    Common Stock, $0.001 par value per share

    (Title of Class of Securities)


    046484309

    (CUSIP Number)


    Braden Leonard,  BML Capital Management, LLC  65 E Cedar - Suite 2  Zionsville,  IN  46077  Phone : 3173442447

    (Name, Address and Telephone Number of Person Authorized to Receive Notices and Communications)


    June 26, 2023

    (Date of Event which Requires Filing of this Statement)



    If the filing person has previously filed a statement on Schedule 13G to report the acquisition that is the subject of this Schedule 13D, and is filing this schedule because of §§240.13d-1(e), 240.13d-1(f) or 240.13d-1(g), check the following box.    x

    Note: Schedules filed in paper format shall include a signed original and five copies of the schedule, including all exhibits. See §240.13d-7 for other parties to whom copies are to be sent.

    * The remainder of this cover page shall be filled out for a reporting person’s initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter disclosures provided in a prior cover page.

    The information required on the remainder of this cover page shall not be deemed to be “filed” for the purpose of Section 18 of the Securities Exchange Act of 1934 (“Act”) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).
     


    1
    NAMES OF REPORTING PERSONS
       
    I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (ENTITIES ONLY)
       
    BML Investment Partners, L.P.
       
       
    2
    CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP
    (a)
    o
     
    (b)
    o
       
    3
    SEC USE ONLY
       
         
       
    4
    SOURCE OF FUNDS
       
    WC
       
       
    5
    CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEM 2(e) or 2(f)
     
    o
     
       
       
    6
    CITIZENSHIP OR PLACE OF ORGANIZATION
       
    Delaware
       
       
    NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH
    7
    SOLE VOTING POWER
       
    0
       
       
    8
    SHARED VOTING POWER
       
    220410
       
       
    9
    SOLE DISPOSITIVE POWER
       
    0
       
       
    10
    SHARED DISPOSITIVE POWER
       
    220410
       
       
    11
    AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
       
    220410
       
       
    12
    CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES
     
    o
     
       
       
    13
    PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)
       
    13.0%
       
       
    14
    TYPE OF REPORTING PERSON
       
    PN
       
       
     
    BML Investment Partners, L.P. is a Delaware limited partnership whose sole general partner is BML Capital Management, LLC. The managing member of BML Capital Management, LLC is Braden M. Leonard. As a result, Braden M. Leonard is deemed to be the indirect owner of the shares held directly by BML Investment Partners, L.P. Despite such shared beneficial ownership, the reporting persons disclaim that they constitute a statutory group within the meaning of Rule 13d-5(b) (1) of the Securities Exchange Act of 1934.
     
    1
    NAMES OF REPORTING PERSONS
       
    I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (ENTITIES ONLY)
       
    Braden M Leonard
       
       
    2
    CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP
    (a)
    o
     
    (b)
    x
       
    3
    SEC USE ONLY
       
         
       
    4
    SOURCE OF FUNDS
       
    PF
       
       
    5
    CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEM 2(e) or 2(f)
     
    o
     
       
       
    6
    CITIZENSHIP OR PLACE OF ORGANIZATION
       
    United States
       
       
    NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH
    7
    SOLE VOTING POWER
       
    11655
       
       
    8
    SHARED VOTING POWER
       
    220410
       
       
    9
    SOLE DISPOSITIVE POWER
       
    11655
       
       
    10
    SHARED DISPOSITIVE POWER
       
    220410
       
       
    11
    AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
       
    232065
       
       
    12
    CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES
     
    o
     
       
       
    13
    PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)
       
    13.7%
       
       
    14
    TYPE OF REPORTING PERSON
       
    IN
       
       
     
    BML Investment Partners, L.P. is a Delaware limited partnership whose sole general partner is BML Capital Management, LLC. The managing member of BML Capital Management, LLC is Braden M. Leonard. As a result, Braden M. Leonard is deemed to be the indirect owner of the shares held directly by BML Investment Partners, L.P. Despite such shared beneficial ownership, the reporting persons disclaim that they constitute a statutory group within the meaning of Rule 13d-5(b)(1) of the Exchange Act.
     
     
     
    Item 1.
    Security and Issuer
      
     
     
    This Statement on Schedule 13D (this “Statement”) relates to shares of Common Stock, par value $0.001 per share (the “Common Stock” or “Shares”) of Astrotech Corporation., a Delaware corporation (the “Issuer”). The address of the principal executive offices of the Issuer is 2105 Donley Drive, Suite 100, Austin, Texas.
     
    Item 2.
    Identity and Background
      
     
     
    (a)
    (a) - (c) This statement is being filed by BML Investment Partners, L.P., a Delaware limited partnership, and Braden M. Leonard. BML Capital Management, LLC, an Indiana limited liability company, is the general partner to BML Investment Partners, L.P. Braden M. Leonard is the sole managing member of the general partner.

     
    (b)
    BML Investment Partners, L.P. - The business address of BML Investment Partners, L.P. is 65 E Cedar – Suite 2, Zionsville, IN 46077. The principal business of BML Investment Partners, L.P. is to purchase, sell, trade and invest in securities.

    BML Capital Management, LLC - The business address of BML Capital Management, LLC is 65 E Cedar – Suite 2, Zionsville, IN 46077. The principal business of BML Capital Management, LLC is to serve as the general partner to BML Investment Partners, L.P.

    Braden M. Leonard – Mr. Leonard’s business address is 65 E Cedar – Suite 2, Zionsville, IN 46077. Mr. Leonard’s principal business is to serve as managing member of BML Capital Management, LLC.

     
    (c)
    See (b).

     
    (d)
    During the past five years, none of BML Investment Partners, L.P., BML Capital Management, LLC or Braden M. Leonard have been convicted in a criminal proceeding (excluding traffic violations or similar misdemeanors) or a party to a civil proceeding of a judicial or administrative body of competent jurisdiction where as a result of such proceeding BML Investment Partners, L.P., BML Capital Management, LLC or Braden M. Leonard was or is subject to a judgment, decree or final order enjoining future violations of, or prohibiting or mandating activities subject to, federal or state securities laws or finding any violation with respect to such laws.

     
    (e)
    During the past five years, none of BML Investment Partners, L.P., BML Capital Management, LLC or Braden M. Leonard have been convicted in a criminal proceeding (excluding traffic violations or similar misdemeanors) or a party to a civil proceeding of a judicial or administrative body of competent jurisdiction where as a result of such proceeding BML Investment Partners, L.P., BML Capital Management, LLC or Braden M. Leonard was or is subject to a judgment, decree or final order enjoining future violations of, or prohibiting or mandating activities subject to, federal or state securities laws or finding any violation with respect to such laws.

     
    (f)
    Braden M. Leonard is a citizen of the United States of America.
     
    Item 3.
    Source and Amount of Funds or Other Consideration
      
     
     
    BML Investment Partners, L.P. holds 220,410 shares of Common Stock which were acquired using approximately $3.77 million of working capital. Braden M. Leonard individually owns 11,655 shares of Common Stock which were acquired using approximately $180,000 of personal funds.
     
    Item 4.
    Purpose of Transaction
      
     
    The Reporting Persons purchased the Common Stock reported hereunder for investment purposes, and such purchases were made in the Reporting Persons’ ordinary course of business. As with their other investments, the Reporting Persons continuously evaluate the Issuer, including but not limited to its businesses, results of operations, and prospects. On June 26, 2023, the Reporting Person sent an acquisition proposal to the Issuer outlining the principal terms on which it would acquire all of the outstanding Common Stock of the Issuer (see exhibit 1). The acquisition proposal provides that it is non-binding and subject to confirmatory diligence, as well as the execution of a definitive merger agreement. The Reporting Persons are filing this Statement as an amendment to their Schedule 13G previously filed on February 8, 2023 . The Reporting Persons intend to engage in discussions with the Issuer and its representatives concerning the acquisition proposal and the proposal contained therein and to enter into negotiations with the Issuer with respect thereto. There can be no certainty as to whether discussions will occur, or if they do, the outcome of such discussions.

    While the Reporting Persons intend to pursue the proposal described in the acquisition proposal, in connection with their investment in the Issuer, the Reporting Persons may, subject to applicable law and regulation, further purchase, hold, vote, trade, dispose of or otherwise deal in the Common Stock at times, and in such manner, as they deem advisable to benefit from, among other things: (1) changes in the market prices of the shares of Common Stock; (2) changes in the Issuer’s operations, business strategy or prospects; or (3) the sale or merger of the Issuer. To evaluate such alternatives, the Reporting Persons will continue to closely monitor the Issuer’s operations, prospects, business development, management, competitive and strategic matters, capital structure, and prevailing market conditions, as well as other economic, securities markets and investment considerations. Consistent with their investment research methods and evaluation criteria, the Reporting Persons may discuss such matters with the management or Board of Directors of the Issuer, industry analysts, existing or potential strategic partners or competitors and investment and financing professionals. Such evaluations and discussions may materially affect, and result in, among other things, the Reporting Persons (1) consummating the transaction contemplated by the acquisition proposal; (2) modifying their ownership of the Common Stock; (3) exchanging information with the Issuer pursuant to appropriate confidentiality or similar agreements; (4) proposing changes in the Issuer’s operations, governance or capitalization; or (5) pursuing one or more of the other actions described in Item 4 of this Schedule 13D.

    In addition to the information disclosed in this Statement, the Reporting Persons reserve the right to: (1) formulate other plans and proposals; (2) take any actions with respect to their investment in the Issuer, including any or all of the actions set forth in Item 4 of this Schedule 13D; and (3) subject to applicable law and regulation, acquire additional shares of Common Stock or dispose of some or all of the shares of Common Stock beneficially owned by them, in each case in the open market, through privately negotiated transactions or otherwise. The Reporting Persons may at any time reconsider and/or change their plans or proposals relating to the foregoing.

     
    (a)

     
    (b)

     
    (c)

     
    (d)

     
    (e)

     
    (f)

     
    (g)

     
    (h)

     
    (i)

     
    (j)
     
    Item 5.
    Interest in Securities of the Issuer
      
     
    (a)
    On June 26, 2023, BML Investment Partners owned 220,410 shares, or 13.0% of the Issuer's Common Stock.

    On June 26, 2023, Braden Leonard owned 11,655 shares, or 0.7%, of the Issuer's Common Stock.

     
    (b)
    Mr. Leonard has sole voting power over 11,655 shares, sole dispositive power over 11,655 shares, shared voting power over 220,410 shares and shared dispositive power over 220,410 shares.

    BML Investment Partners, L.P. has sole voting power over 0 shares, sole dispositive power over 0 shares, shared voting power over 220,410 shares and shared dispositive power over 220,410 shares.

     
    (c)
    None.

     
     
    Transaction Date Shares or Units Purchased (Sold) Price Per Share or Unit 
     
     

     
     
     

     
     

     
    (d)

     
    (e)
     
    Item 6.
    Contracts, Arrangements, Understandings or Relationships with Respect to Securities of the Issuer
      
     
     
     
    Item 7.
    Material to Be Filed as Exhibits
      
     
     
    Exhibit 1

    BML Capital Management, LLC
    65 E Cedar, Suite 2 | Zionsville, IN 46077


    June 26, 2023
    Board of Directors
    Astrotech Corporation
    c/o Thomas B. Pickens III, Chief Executive Officer
    2105 Donley Drive, Suite 100
    Austin, Texas 78758

    Dear Directors,

    As you are aware, BML Investment Partners, L.P. owns 13% of the shares of Astrotech and is
    your largest shareholder. I was disappointed to see the company file an at-the-market (ATM)
    offering on June 16, 2023. I believe that your shares are significantly undervalued, as they trade
    at a large discount to net cash, and that any shares issued at this level would rapidly destroy
    shareholder value. Considering these facts, I believe that shareholders would be better off if the
    company was either sold or liquidated.

    On behalf of BML Capital Management, LLC and BML Investment Partners, L.P., I am pleased
    to submit this non-binding proposal to acquire 100% of the equity of Astrotech Corporation for
    $17.25 per share in cash, which represents a 50% premium to the closing price on Friday, June
    23.

    This proposal is subject to limited confirmatory due diligence and is based on Astrotech having
    at least $35 million of cash and cash equivalents at closing, net of any tail and closing costs, and
    not having issued any shares under the ATM offering. This proposal is not subject to any
    financing contingency, as we have funds readily available to close this transaction.

    I believe that this proposal represents a compelling offer for Astrotech stockholders. I hope that
    you share this view and look forward to discussing it with you further. I would appreciate a
    response by 5pm ET on June 30, 2023, at which point this offer will expire.

    Sincerely,

    Braden Leonard
     

    Signature
     
    After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

     
    BML Capital Management, LLC
     
           
    June 26, 2023
    By:
    /s/ Braden M Leonard
     
       
    Managing Member
     
           
     
     
           
    June 26, 2023
    By:
    /s/ Braden M Leonard
     
       
     
           
     
    The original statement shall be signed by each person on whose behalf the statement is filed or his authorized representative. If the statement is signed on behalf of a person by his authorized representative (other than an executive officer or general partner of the filing person), evidence of the representative’s authority to sign on behalf of such person shall be filed with the statement: provided, however, that a power of attorney for this purpose which is already on file with the Commission may be incorporated by reference. The name and any title of each person who signs the statement shall be typed or printed beneath his signature.

    Footnotes: 
     
    Attention: Intentional misstatements or omissions of fact constitute Federal criminal violations (See 18 U.S.C. 1001)
     
     


    Get the next $ASTC alert in real time by email

    Chat with this insight

    Save time and jump to the most important pieces.

    Recent Analyst Ratings for
    $ASTC

    DatePrice TargetRatingAnalyst
    More analyst ratings

    $ASTC
    Financials

    Live finance-specific insights

    See more
    • Astrotech Announces Listing to the GSA as an Approved United States Government Vendor

      Astrotech Announces Listing to the GSA as an Approved United States Government Vendor AUSTIN, Texas, April 08, 2024 (GLOBE NEWSWIRE) -- Astrotech Corporation (NASDAQ:ASTC) ("Astrotech" or the "Company") and its wholly owned subsidiary, 1st Detect Corporation (1st Detect), announce that 1st Detect's TRACER 1000TM is now listed in the U.S. General Services Administration (GSA) IT Schedule 70 under Contract No. GS-35F-250GA with SRI Group LLC, Special Item Number 334290.   IT Schedule 70 is a long-term contract issued by the GSA to commercial technology vendors that allows sales to the U. S. federal government, one of the largest buyers of goods and services in the world. GSA's thoro

      4/8/24 9:00:00 AM ET
      $ASTC
      Biotechnology: Laboratory Analytical Instruments
      Industrials
    • Astrotech to Showcase the Tracer 1000 Trace Detector at ISC West Conference

      AUSTIN, Texas, April 02, 2024 (GLOBE NEWSWIRE) -- Astrotech Corporation (NASDAQ:ASTC) ("Astrotech" or the "Company") and its wholly owned subsidiary, 1st Detect Corporation, announces that it will be showcasing its TRACER 1000 Narcotics Trace Detector ("NTD") and Explosives Trace Detector ("ETD") at the International Security Conference and Exposition, also known as ISC West, in Las Vegas, Nevada, from April 9-12, 2024, in booth number 2067. The TRACER 1000 is a high-performance laboratory instrument that is powered by the Astrotech Mass Spectrometer Technology™ ("AMS Technology"). Our mass spectrometer is capable of rapid detection of trace levels of narcotic or explosive compounds in

      4/2/24 9:00:00 AM ET
      $ASTC
      Biotechnology: Laboratory Analytical Instruments
      Industrials
    • Astrotech Introduces the "Gold Standard" of Mass Spectrometry into Narcotics Detection Market with its State-of-the-Art Tracer 1000

       AUSTIN, Texas, March 25, 2024 (GLOBE NEWSWIRE) -- Astrotech Corporation (NASDAQ:ASTC) ("Astrotech" or the "Company") and its wholly owned subsidiary, 1st Detect Corporation, announces that it is currently accepting orders for the Tracer 1000 Narcotics Trace Detector (NTD). The TRACER 1000 NTD is a high-performance laboratory instrument capable of rapid detection of trace levels of narcotic compounds in seconds. Currently, the Company's Tracer 1000 Explosive Trace Detector (ETD) is now found in multiple locations in 14 countries throughout the world. The NTD provides a ruggedized platform that can be applied across various markets including airports, border security, checkpoint, cargo,

      3/25/24 9:00:00 AM ET
      $ASTC
      Biotechnology: Laboratory Analytical Instruments
      Industrials

    $ASTC
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    See more
    • SEC Form SC 13D filed by Astrotech Corporation (DE)

      SC 13D - ASTROTECH Corp (0001001907) (Subject)

      6/26/23 4:00:53 PM ET
      $ASTC
      Biotechnology: Laboratory Analytical Instruments
      Industrials
    • SEC Form SC 13G/A filed by Astrotech Corporation (DE) (Amendment)

      SC 13G/A - ASTROTECH Corp (0001001907) (Subject)

      2/8/23 5:29:16 PM ET
      $ASTC
      Biotechnology: Laboratory Analytical Instruments
      Industrials
    • SEC Form SC 13G/A filed by Astrotech Corporation (DE) (Amendment)

      SC 13G/A - ASTROTECH Corp (0001001907) (Subject)

      2/8/23 4:02:50 PM ET
      $ASTC
      Biotechnology: Laboratory Analytical Instruments
      Industrials

    $ASTC
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • Director Mcfarland Robert N was granted 3,000 shares, increasing direct ownership by 28% to 13,900 units (SEC Form 4)

      4 - ASTROTECH Corp (0001001907) (Issuer)

      5/16/25 11:38:34 AM ET
      $ASTC
      Biotechnology: Laboratory Analytical Instruments
      Industrials
    • Director Stober Eric was granted 3,000 shares, increasing direct ownership by 41% to 10,331 units (SEC Form 4)

      4 - ASTROTECH Corp (0001001907) (Issuer)

      5/16/25 10:47:45 AM ET
      $ASTC
      Biotechnology: Laboratory Analytical Instruments
      Industrials
    • CEO Pickens Thomas Boone Iii was granted 50,000 shares, increasing direct ownership by 38% to 181,385 units (SEC Form 4)

      4 - ASTROTECH Corp (0001001907) (Issuer)

      5/16/25 10:46:04 AM ET
      $ASTC
      Biotechnology: Laboratory Analytical Instruments
      Industrials

    $ASTC
    Press Releases

    Fastest customizable press release news feed in the world

    See more
    • Astrotech Reports Third Quarter of Fiscal Year 2025 Financial Results

      AUSTIN, Texas, May 13, 2025 (GLOBE NEWSWIRE) -- Astrotech Corporation (NASDAQ:ASTC) (the "Company" or "Astrotech") reported its financial results for the third quarter of fiscal year 2025, which ended March 31, 2025. Thomas B. Pickens, III, Astrotech's Chairman, Chief Executive Officer and Chief Technology Officer, said, "Our customizable, portable and field updatable mass spectrometry instruments have the potential to be a game changer in a growing list of large end markets such as airport security and cargo scanning, narcotics detection, environmental monitoring and chemical processing. I am very proud of our team's accomplishments, as we now have launched four product lines that we bel

      5/13/25 4:30:00 PM ET
      $ASTC
      Biotechnology: Laboratory Analytical Instruments
      Industrials
    • 1st Detect Unveils Enhanced TRACER 1000 Narcotics Trace Detector Intended to Combat Synthetic Opiates and Novel Psychoactive Substances

      AUSTIN, Texas, March 10, 2025 (GLOBE NEWSWIRE) --  Astrotech Corporation (NASDAQ:ASTC) today announced the launch of its enhanced TRACER 1000™ Narcotics Trace Detector ("TRACER 1000 NTD") from its 1st Detect subsidiary. This innovative mobilized mass spectrometer is specifically configured to screen for the full range of synthetic opiates and novel psychoactive substances ("NPS"), delivering accuracy and speed to counter the global drug crisis. Improving Drug Detection with Advanced Mass Spectrometry The latest iteration of the TRACER 1000 NTD represents a significant leap forward in portable trace detection. Unlike conventional methods, the TRACER 1000 NTD leverages cutting-edge mass sp

      3/10/25 8:30:00 AM ET
      $ASTC
      Biotechnology: Laboratory Analytical Instruments
      Industrials
    • Astrotech Creates New Subsidiary EN-SCAN, Inc.

      AUSTIN, Texas, Feb. 28, 2025 (GLOBE NEWSWIRE) -- Astrotech Corporation (NASDAQ:ASTC) announced today that it has created a new wholly owned subsidiary, EN-SCAN, Inc. ("EN-SCAN"), to manufacture and sell a new line of instruments built for environmental testing applications using its proprietary ATi Gas Chromatograph ("GC") and Astrotech Mass Spectrometer Technology™ ("MS"). The EN-SCAN product line has been designed for outdoor field work that can be used on-site for real-time air, water, and soil analysis providing instant feedback for accurate contamination source location and migration. "EN-SCAN has been developed to fill a gap in the environmental testing market needing a durable and

      2/28/25 8:30:00 AM ET
      $ASTC
      Biotechnology: Laboratory Analytical Instruments
      Industrials

    $ASTC
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • Becker James Frank bought $19,675 worth of shares (2,034 units at $9.67), increasing direct ownership by 14% to 16,121 units (SEC Form 4)

      4 - ASTROTECH Corp (0001001907) (Issuer)

      5/30/24 9:16:58 AM ET
      $ASTC
      Biotechnology: Laboratory Analytical Instruments
      Industrials
    • Hinojosa Jaime bought $8,541 worth of shares (900 units at $9.49), increasing direct ownership by 13% to 7,881 units (SEC Form 4)

      4 - ASTROTECH Corp (0001001907) (Issuer)

      5/28/24 9:46:54 AM ET
      $ASTC
      Biotechnology: Laboratory Analytical Instruments
      Industrials
    • Wilkinson Thomas Wiley bought $10,536 worth of shares (1,109 units at $9.50), increasing direct ownership by 6% to 20,862 units (SEC Form 4)

      4 - ASTROTECH Corp (0001001907) (Issuer)

      5/21/24 12:54:36 PM ET
      $ASTC
      Biotechnology: Laboratory Analytical Instruments
      Industrials

    $ASTC
    Leadership Updates

    Live Leadership Updates

    See more
    • Jaime Hinojosa Resigns as Chief Financial Officer to Work in Family Business

      AUSTIN, Texas, Jan. 24, 2025 (GLOBE NEWSWIRE) -- Astrotech Corporation (NASDAQ:ASTC) ("Astrotech" or the "Company") announced the resignation of its Chief Financial Officer, Jaime Hinojosa, effective February 14, 2025.   Mr. Hinojosa will continue to serve in the CFO role until February 14, 2025, and after that time will provide transition services to the Company on a consulting basis through June 30, 2025. In connection with this development, the Company and its Board of Directors have appointed Ryan Polk to serve as interim Chief Financial Officer. "I will be moving to Houston to be closer to family and to work for our family business," said Mr. Hinojosa. "I am grateful to Tom Pickens,

      1/24/25 8:30:00 AM ET
      $ASTC
      Biotechnology: Laboratory Analytical Instruments
      Industrials
    • Astrotech Reports First Quarter of Fiscal Year 2024 Financial Results

      AUSTIN, Texas, Nov. 13, 2023 (GLOBE NEWSWIRE) -- Astrotech Corporation (NASDAQ:ASTC) (the "Company" or "Astrotech") reported its financial results for the first quarter of fiscal year 2024, which ended September 30, 2023. Financial Highlights & Recent Developments  Astrotech's consolidated balance sheet remains strong with $39 million in cash and liquid investments, which are anticipated to support our research and development, organic growth, and potential acquisition targets.Revenue for the quarter totaled $425 thousand compared to $38 thousand in the first quarter of the prior year due primarily to ongoing fulfillment of the previously announced 17-unit order for the TRACER 1000™ expl

      11/13/23 4:30:30 PM ET
      $ASTC
      Biotechnology: Laboratory Analytical Instruments
      Industrials
    • LogicMark Expands its Board of Directors by Naming Carine Schneider and Tom Wilkinson as Company's Innovative Product Pipeline Continues to Grow (Updated with Additional Details)

      LOUISVILLE, Ky., Oct. 31, 2023 (GLOBE NEWSWIRE) -- LogicMark, Inc. (NASDAQ:LGMK) (the "Company"), creator of the most innovative personal safety and security technology designed for the care economy, today announced that Carine Schneider, FGE, and Tom Wilkinson will join as the newest members of its Board of Directors. Ms. Schneider and Mr. Wilkinson both bring decades of corporate governance, finance, operations, technology, M&A, advisory and CEO experience. "I am thrilled to welcome Carine and Tom to our Board of Directors. Carine's demonstrated history of leadership and innovation in the technology and finance sectors, coupled with Tom's extensive experience and influential work with a

      10/31/23 11:54:15 AM ET
      $ASTC
      $LGMK
      $SONM
      Biotechnology: Laboratory Analytical Instruments
      Industrials
      Industrial Specialties
      Health Care

    $ASTC
    SEC Filings

    See more
    • SEC Form 10-Q filed by Astrotech Corporation (DE)

      10-Q - ASTROTECH Corp (0001001907) (Filer)

      5/14/25 9:20:19 AM ET
      $ASTC
      Biotechnology: Laboratory Analytical Instruments
      Industrials
    • Astrotech Corporation (DE) filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits

      8-K - ASTROTECH Corp (0001001907) (Filer)

      5/13/25 4:33:56 PM ET
      $ASTC
      Biotechnology: Laboratory Analytical Instruments
      Industrials
    • Astrotech Corporation (DE) filed SEC Form 8-K: Regulation FD Disclosure, Financial Statements and Exhibits

      8-K - ASTROTECH Corp (0001001907) (Filer)

      3/10/25 8:31:49 AM ET
      $ASTC
      Biotechnology: Laboratory Analytical Instruments
      Industrials